All Stories

  1. The Immunomodulatory Role of Vitamin D in Respiratory Diseases
  2. Genetic Anomalies of the Respiratory Tract
  3. Genetic Disorders of Surfactant Deficiency and Neonatal Lung Disease
  4. An Overview of HMGB1 and its Potential Role as a Biomarker for RSV Infection
  5. Novel Biologics for the Treatment of Pediatric Severe Asthma
  6. Biomarkers in Pediatric Lung Diseases Including Cystic Fibrosis
  7. Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis
  8. Study of lung injury in children undergoing chemotherapy.
  9. Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives
  10. Novel therapeutic targets for allergic airway disease in children
  11. Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat
  12. Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review
  13. Key paediatric messages from the 2018 European Respiratory Society International Congress
  14. General anesthesia, conscious sedation, or nothing: Decision‐making by children during painful procedures
  15. Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria
  16. Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease
  17. Minor pulmonary malformations in a child
  18. Zooming in on the ERS fellowships and the International Congress
  19. Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease
  20. Focus on Pleiotropic Role of HMGB1 in the Onset of Allergic and Non- Allergic Respiratory Diseases
  21. Probiotics Role in Allergic Illness
  22. HMGB1 values and response to HBV vaccine in children with celiac disease
  23. HMGB1 as a new biomarker of celiac disease in children: A multicenter study
  24. High mobility group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate-severe asthma
  25. Severe disease in Cystic Fibrosis and fecal calprotectin levels
  26. YKL-40 as marker of severe lung disease in cystic fibrosis patients
  27. Immune system network in allergic diseases during sublingual immunotherapy: The role of oral mucosal tissue
  28. Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children?
  29. Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): Association with clinical severity and phenotype
  30. Severe Kawasaki disease in a 3-month-old patient: a case report
  31. Liver Disease in Cystic Fibrosis: an Update
  32. Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients